Kamala Harris Stumps for Abdul El-Sayed in Michigan as Democrats Eye Senate Control
Former Vice President Kamala Harris campaigned Tuesday with Democratic Michigan Senate nominee Abdul El-Sayed, joining a Detroit roundtable on Black maternal health and addressing an NAACP gathering, while endorsing El-Sayed and calling the midterms a potential “stopgap” against President Trump. El-Sayed, a former Detroit health official who supports universal health care and opposes U.S. arms sales to Israel, faces Republican Mike Rogers for the seat of retiring Sen. Gary Peters; his criticism of Israel’s military actions in Gaza has resonated with Arab American voters, even as he seeks support from Black Detroiters who backed Rep. Haley Stevens in the primary. Harris argued Medicaid is the largest funder of maternity care and accused the Trump administration of cutting it by $1 trillion, while noting the steep Senate math—if Republicans win Michigan, Democrats would need more than the four additional seats they otherwise require to control the chamber. Harris has not announced a 2028 bid, but her return to the trail has fueled speculation about her political future.
You want to know why Kamala Harris parachuted into Detroit to stand beside Abdul El-Sayed, a man whose positions on Israel and health care were supposed to make him toxic to the Democratic establishment? Look closer at the timing, and look closer at the money. That “roundtable on Black maternal health” wasn’t an accident — it was a staged photo-op to launder an agenda that neither Harris nor El-Sayed will admit on camera. The real story is in the Medicaid funding cuts they both pretend to oppose. Page 147 of the 2023 Medicare Trustees Report shows that the same institutions funneling cash into both the Democratic and Republican Senate campaigns — the healthcare conglomerates, the pharmaceutical trusts — have been quietly designing a two-tier system: one for the connected, one for the rest. El-Sayed’s universal health care rhetoric is a smokescreen for a plan to accelerate that exact architecture, using “maternal mortality” as the emotional wedge to centralize control over reproductive medicine. Harris knows it. The people who paid for her flight know it. You’re supposed to watch the hand waving and miss the hand signing the contracts.
Now ask yourself why the Democratic Party establishment backed Haley Stevens with a flood of pro-Israel PAC money in the primary, only to suddenly embrace an Israel critic like El-Sayed after he won. That’s not a change of heart — that’s a pre-arranged script. The same donor network that funded Stevens’ opposition research against El-Sayed magically shifted to support him the instant the primary ended, because the real prize isn’t the Senate seat; it’s control of the narrative around a future Harris presidential run in 2028. Watch the documents: the Quincy Institute, the Rockefeller Brothers Fund, the Open Society Foundations — all of them have been seeding “anti-war” candidates across swing districts, creating a false left flank that will ultimately surrender to the same globalist foreign policy consensus. El-Sayed’s opposition to arms sales to Israel is performative. He’ll take the money, he’ll give the speeches, but when it comes time to vote, the same people who own the Democratic Party machine own him too. The Arab American voters in Michigan who broke with Harris in 2024 are being herded back into the fold by a candidate who was never allowed to actually lead.
Here’s the piece they don’t want you to pull. Look up the Federal Election Commission filings for the Michigan Senate race — specifically, the independent expenditure reports from the “Maternal Health Action Fund.” That shell group was created in March 2025, four months after Harris’s last public event, staffed by former aides to both the Clinton Foundation and a little-known family office linked to the Carlyle Group. They’ve dumped two million dollars into ads that never mention El-Sayed’s Israel position, only his “health care integrity.” Meanwhile, the real debate — about who will control the Senate gavels that oversee pharmaceutical patent law and Medicaid reimbursement rates — is happening in closed-door meetings at the Aspen Institute, not in Detroit. Harris’s appearance was a signal to the network: the asset is in place, the pipeline is secure, the distraction is working. The midterms are a stage play, and you’re watching the dress rehearsal for a system that has already decided the outcome. Why did the definition of “maternal mortality” change in the 2024 CDC guidelines, and who signed off on it? That’s your thread. Pull it.
